弱磁场下三阱光学超晶格中自旋为1的超冷原子特性研究

双阱光学超晶格中的超冷原子是近期冷原子物理领域的研究热点. 本文推广提出了实现三阱光学超晶格的方案, 并采用精确对角化的方法分别研究了弱磁场下对称三阱 光学超晶格中铁磁性和反铁磁性的自旋为1的原子系统的基态, 发现二者的相图很不相同: 反铁磁性原子对应的相图中没有沿磁场方向总自旋磁量子数为±2的基态, 而铁磁性原子对应的相图中可能有. 在负的二次塞曼能量区域, 铁磁性原子的相图中只有完全极化态. 分析了可控参数影响基态的物理本质. 由于这些量子自旋态可以通过调节外磁场和光势垒的高度非常简便而精确地控制, 适合用来研究自旋纠缠. 关键词： 三阱光学超晶格 自旋为1的原子 弱磁场     

Eu_(0.9)M_(0.1)TiO_3(M=Ca,Sr,Ba,La,Ce,Sm)的磁性和磁热效应

EuTi0_3是直接带隙半导体材料,在液氦温度附近呈现反铁磁性,且具有较大的磁熵变,但是当其转变为铁磁性时,可以有效提高低磁场下的磁熵变.本文通过元素替代,研究晶格常数的变化和电子掺杂对磁性和磁热效应的影响.实验采用溶胶凝胶法制备EuTiO_3和Eu_(0.9)M_(0.1)TiO_3 (M=Ca, Sr, Ba, La, Ce, Sm)系列样品.结果表明:大离子半径的碱土金属离子替代提高了铁磁性耦合,有利于提高低磁场下的磁热效应.电子掺杂可以抑制其反铁磁性耦合从而使其表现为铁磁性.当大离子半径的稀土La和Ce离子替代Eu离子时,既增大了晶格常数也实现了电子掺杂,表现出较强的铁磁性.在1 T的磁场变化下,Eu_(0.9)La_(0.1)TiO_3和Eu_(0.9)Ce_(0.1)TiO_3的最大磁熵变分别为10.8和11 J/(kg·K),均大于EuTi0_3的9.8 J/(kg·K);制冷能力分别为39.3和51.8 J/kg,相对于EuTi0_3也有所提高.     

磁场及体各向异性对面心立方双层铁磁薄膜能带的影响

利用二次量子化方法研究了由相同面心立方结构(100)材料构成的铁磁性双层薄膜,重点讨论了磁场及体各向异性对面心立方双层铁磁薄膜能带的影响.结果表明,无论界面为铁磁性界面交换作用或反铁磁性界面交换作用,磁场及各向异性场对对称薄膜中的自旋波存在方式及整个能带形状没有影响,只是影响整个激发模的能量.磁场和各向异性常数越大,自旋波能量越高.     

中心对称的阻挫磁体中斯格明子直径的调节

在带有垂直各向异性的二维三角晶格磁体中,当同时存在最近邻铁磁性和第三近邻反铁磁性交换作用时,垂直于膜面施加外磁场会使体系内自旋沿着非共面的方向排列,甚至出现拓扑稳定的斯格明子自旋结构.基于蒙特卡罗模拟方法,本文研究了在该二维阻挫磁体中,竞争性交换作用和外磁场对斯格明子直径的影响.与常规非中心对称的手性磁体中的斯格明子性质类似,外磁场会磁化斯格明子外围自旋而减小斯格明子直径.但是,磁体中反铁磁性交换作用的增强会整体压缩斯格明子.本文结合自旋波理论和蒙特卡罗模拟,首次量化了此类阻挫磁体中斯格明子的直径.结果表明:在弱的反铁磁性交换作用磁体中,斯格明子直径随磁场增大而快速线性减小;随着反铁磁性交换作用的增大,斯格明子直径随外磁场增大的减小变得相对平缓,但在强磁场下也会造成斯格明子直径的加速减小;随着反铁磁性交换作用的增强,斯格明子在不同外磁场下的直径的最大值和中值均从逐渐减小到渐趋稳定,而直径的最小值则从快速减小到表现出很大的涨落.这些现象都可以通过分析斯格明子在不同交换作用和外磁场下的构型和磁能变化加以解释.该项工作阐明了在中心对称的阻挫磁体中斯格明子直径的可调节性,不仅完善了我们对斯格明子本身物理机理的认识,同时也为发展基于斯格明子的新一代存储和逻辑器件提供了理论支撑.     

Ge纳米结构的形貌与铁磁性研究

利用等离子体增强化学气相沉积技术制备了厚度不同的Ge薄膜, 随着样品厚度的减小, 样品表现出了室温铁磁性. 厚度为12 nm样品经过300 ℃退火后, 由于颗粒细化, 颗粒之间的界面增加, 界面缺陷增加, 样品表现出最大的铁磁性 (50 emu/cm³). 场冷却和零场冷却曲线测试表明居里温度约为350 K. 进行600 ℃退火后, 颗粒团聚, 样品的铁磁性最小. 当样品厚度进一步减小为6 nm时, 沉积态样品表现出铁磁性和顺磁性共存. 对6 nm厚的样品进行300 ℃退火后, 样品只具有铁磁性. 进行600 ℃退火后, 样品却只具有顺磁性. 12 nm 和6 nm 厚的Ge纳米结构薄膜随退火温度变化表现出不同的磁性规律, 我们认为是由于样品的颗粒大小和颗粒分布不同造成的. 样品越薄, Si基底与Ge薄膜之间的界面缺陷越明显, 界面缺陷以及Ge颗粒之间的界面缺陷为样品提供了未配对电子, 未配对电子的铁磁性耦合强度与样品颗粒的分布以及颗粒之间的结合有一定的关系. 颗粒之间分散或颗粒之间的融合程度大都将会降低样品的铁磁性.     

类钙钛矿化合物Ca（Mn2Cu1）Mn4O12的磁性与磁电阻效应

利用固相反应法制备了名义成分为Ca(Mn2Cu1)Mn4O12的类钙钛矿锰氧化物.x射线衍射表明，为了获得较为致密的样品和减小杂相含量，可以采用高温烧结再在1073K长时间空气中退火的制备方法.样品在低温下同时存在铁磁相和反铁磁相，由于反铁磁相的存在导致样品在4.5K时的磁化强度显著降低，并在8T的高磁场下仍未达到饱和.样品呈半导体导电性质，在85K和6T磁场下磁电阻比的最大值可达-46%. 关键词： ［AC3］(B4)O12类钙钛矿锰氧化物 庞磁电阻效应 铁磁性 反铁磁性     

陀螺仪特斯拉计的相关讨论

当一个由非铁磁性导体制成的陀螺仪,被放置在磁场中时,其由于旋转切割磁感线会受到制动力矩的作用,从而会发生减速.本文首先将此模型简化为非铁磁性导体圆盘在磁场中的运动,通过求解体系所满足的麦克斯韦方程组,结合实验现象进行了解释;再总结出导体圆盘的角速度变化与外界磁场大小的关系,并将其用于制作一个陀螺仪特斯拉计,对其测量结果...     

原位磁场下粉末样品的X射线衍射图谱

在X射线粉末衍射仪的样品台附近施加磁场 ,测得了在原位磁场下分别具有顺磁性、抗磁性、铁磁性、亚铁磁性、反铁磁性和磁性混合物的 6个样品的X射线衍射图谱 .与无磁场时的相应衍射图谱相比较 ,这些图谱中有衍射峰消失 ,又有新的衍射峰出现 ;或是峰位置和强度发生变化 ;而且磁场方向不同时 ,衍射图谱也不一样 .产生这些现象的部分原因可能是 ,在磁场下物质内部的磁矩沿着磁场方向定向 ,粉末晶胞内产生应力 ,导致晶格歧变 (如磁致伸缩效应 )或者晶粒沿着易磁化轴方向择优取向     

磁流变弹性体中结合胶的存在及其对材料性能的影响

为了提高磁流变材料的力学磁学性能，在大量的实验和观测过程中，发现了在磁流变弹性体的内部存在结合橡胶现象．进一步的实验证实了铁磁性颗粒表面的确存在结合橡胶，并且这层结合橡胶的厚度和铁磁性颗粒的大小之间的相互关系对材料的性能有显著的影响．通过理论分析和实验测试发现，通过提高颗粒半径和结合橡胶厚度的比率，可以显著提高磁流变弹性体的磁流变性能．     

控制纳米结构以调控氧化锌的发光、磁性和细胞毒性

氧化锌(ZnO) 纳米材料因其在UV 激光器、发光二极管、太阳能电池、稀磁半导体、生物荧光标示、靶向药物等领域中的广泛应用而成为最热门的研究课题之一. 调节和优化ZnO 纳米结构的性质是ZnO 的实际应用迫切所需. 在此, 通过发展聚乙烯吡咯烷酮导向结晶法、微波加热强制水解法、表面活性剂后处理法, 成功地制备出了尺寸、表面电荷或成分可调的球、半球、棒、管、T 型管、三脚架、片、齿轮、两层、多层、带盖罐子、碗等一系列ZnO 纳米结构. 通过简单地改变ZnO 纳米粒子的尺寸、形貌和表面电荷或成分, 有效地调控ZnO 本身的发光强度和位置, 并近90 倍地增强了荧光素染料的荧光强度; 诱使了强度可调的室温铁磁性; 实现了对ZnO纳米颗粒的细胞毒性的系统性调控.     

Application of high gradient magnetic separation principles to magnetic drug targeting

A hypothetical magnetic drug targeting system, utilizing high gradient magnetic separation (HGMS) principles, was studied theoretically using FEMLAB simulations. This new approach uses a ferromagnetic wire placed at a bifurcation point inside a blood vessel and an externally applied magnetic field, to magnetically guide magnetic drug carrier particles (MDCP) through the circulatory system and then to magnetically retain them at a target site. Wire collection (CE) and diversion (DE) efficiencies were defined and used to evaluate the system performance. CE and DE both increase as the strength of the applied magnetic field (0.3–2.0 T), the amount of ferromagnetic material (iron) in the MDCP (20–100%) and the size of the MDCP (1–10 μm radius) increase, and as the average inlet velocity (0.1–0.8 m s⁻¹), the size of the wire (50–250 μm radius) and the ratio (4–10) of the parent vessel radius (0.25–1.25 mm radius) to wire radius decrease. The effect of the applied magnetic field direction (0° and 90°) on CE and DE was minimal. Under these plausible conditions, CEs as high as 70% were obtained, with DEs reaching only 30%; however, when the MDCPs were allowed to agglomerate (4–10 μm radius), CEs and DEs of 100% were indeed achieved. These results reveal that this new magnetic drug targeting approach for magnetically collecting MDCPs at a target site, even in arteries with very high velocities, is feasible and very promising; this new approach for magnetically guiding MDCPs through the circulatory system is also feasible but more limited. Overall, this study shows that magnetic drug targeting, based on HGMS principles, has considerable promise as an effective drug targeting tool with many potential applications.     

Ferromagnetic seeding for the magnetic targeting of drugs and radiation in capillary beds

A new implant assisted-magnetic drug targeting approach is introduced and theoretically analyzed to demonstrate its feasibility. This approach uses ferromagnetic particles as seeds for collecting magnetic drug carrier particles at the desired site in the body, such as in a capillary bed near a tumor. Based on the capture cross section (λ_c) approach, a parametric study was carried out using a 2-D mathematical model to reveal the effects of the magnetic field strength (μ₀H₀=0.01–1.0 T), magnetic drug carrier particle radius (R_p=20–500 nm), magnetic drug carrier particle ferromagnetic material content (x_fm,p=20–80 wt%), average blood velocity (u_B=0.05–1.0 cm/s), seed radius (R_s=100–2000 nm), number of seeds (N_s=1–8), seed separation (h=0–8R_s), and magnetic drug carrier particle and seed ferromagnetic material saturation magnetizations (iron, SS 409, magnetite, and SS 304) on the performance of the system. Increasing the magnetic field strength, magnetic drug carrier particle size, seed size, magnetic drug carrier particle ferromagnetic material content, or magnetic drug carrier particle or seed saturation magnetization, all positively and significantly affected λ_c, while increasing the average blood velocity adversely affected it. Increasing the number of seeds or decreasing the seed separation, with both causing less significant increases in λ_c, verified that cooperative magnetic effects exist between the seeds that enhance the performance. Overall, these theoretical results were encouraging as they showed the viability of this minimally invasive, implant assisted-magnetic drug targeting approach for targeting drugs or radiation in capillary beds.     

Exchange couplings in magnetic films

Recent advances in the study of exchange couplings in magnetic films are introduced.To provide a comprehensive understanding of exchange coupling,we have designed different bilayers,trilayers and multilayers,such as anisotropic hard/soft-magnetic multilayer films,ferromagnetic/antiferromagnetic/ferromagnetic trilayers,[Pt/Co]/NiFe/NiO heterostructures,Co/NiO and Co/NiO/Fe trilayers on an anodic aluminum oxide(AAO) template.The exchange-coupling interaction between soft-and hard-magnetic phases,interlayer and interfacial exchange couplings and magnetic and magnetotransport properties in these magnetic films have been investigated in detail by adjusting the magnetic anisotropy of ferromagnetic layers and by changing the thickness of the spacer layer,ferromagnetic layer,and antiferromagnetic layer.Some particular physical phenomena have been observed and explained.     

Magnetization reversal of ferromagnetic nanoparticles under inhomogeneous magnetic field

We investigated remagnetization processes in ferromagnetic nanoparticles under inhomogeneous magnetic field induced by the tip of magnetic force microscope (MFM) in both theoretical and empirical ways. Systematic MFM observations were carried out on arrays of submicron-sized elliptical ferromagnetic particles of Co and FeCr with different sizes and periods. It clearly reveals the distribution of remanent magnetization and processes of local remagnetization of individual ferromagnetic particles. Modeling of remagnetization processes in ferromagnetic nanoparticles under magnetic field induced by MFM probe was performed on the base of Landau–Lifshitz–Gilbert equation for magnetization. MFM-induced inhomogeneous magnetic field is very effective to control the magnetic state of individual ferromagnetic nanoparticles as well as to create different distribution of magnetic field in array of ferromagnetic nanoparticles.     

Determining the magnetic ground state of TbNi5 single crystal using polarized neutron scattering technique

The TbNi₅ compound shows an interesting magnetic phase transition with an incommensurate structure below 23 K, whose true nature remains unresolved. In order to solve this question, we have carried out polarized neutron diffraction experiments by measuring temperature and field dependence of the intensities of satellites and Bragg reflections. From the temperature dependence of both satellite peaks and Bragg reflection, we demonstrated that it has only one magnetic structure at a given temperature. Furthermore, unlike previous reports, we found that both ferromagnetic and modulated components of the Tb ion magnetic moments should be collinear to each other. Our data also show strong depolarisation effects that are most likely to arise from domain structure of ferromagnetic component. A critical field, which destroyers a modulated magnetic structure is found to be lower than a field value to saturate the ferromagnetic component, in which the intensity of Bragg ferromagnetic reflections reaches saturation.     

Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: Parametric study with multi-wire two-dimensional model

A 2-D mathematical model was developed and used to examine the capture of magnetic drug carrier particles (MDCPs) by a magnetizable intravascular stent (MIS). The roles of both non-stent system parameters, i.e., the blood flow rate, magnetic field strength and direction and MDCP properties, and stent design parameters, i.e., the MIS radius, its wire radius, number of MIS loops, interwire loop spacing and MIS ferromagnetic material were evaluated over a wide range of plausible conditions. The results showed that the MIS could be a very effective magnetic drug targeting tool with many possible applications.     

Stray field magnetic resonance tomography using ferromagnetic spheres

The methodology for obtaining two- and three-dimensional magnetic resonance images by using azimuthally symmetric dipolar magnetic fields from ferromagnetic spheres is described. We utilize the symmetric property of a geometric sphere in the presence of a large externally applied magnetic field to demonstrate that a complete two- or three-dimensional structured rendering of a sample can be obtained without the motion of the sample relative to the sphere. Sequential positioning of the integrated sample-sphere system in an external magnetic field at various angular orientations provides all the required imaging slices for successful computerized tomographic image reconstruction. The elimination of the requirement to scan the sample relative to the ferromagnetic tip in this imaging protocol is a potentially valuable simplification compared to previous scanning probe magnetic resonance imaging proposals.     

Theoretical analysis of a transdermal ferromagnetic implant for retention of magnetic drug carrier particles

The use of a ferromagnetic wire implant placed near an artery to assist the collection of magnetic drug carrier particles (MDCPs) using an external magnet is theoretically studied. Three magnetic drug targeting (MDT) systems are evaluated in terms of their MDCP collection efficiency (CE): a permanent magnet and wire is better than a permanent magnet alone, which is better than a homogeneous magnetic field and wire.     

Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body

Magnetic drug delivery has the potential to target therapy to specific regions in the body, improving efficacy and reducing side effects for treatment of cancer, stroke, infection, and other diseases. Using stationary external magnets, which attract the magnetic drug carriers, this treatment is limited to shallow targets (<5 cm below skin depth using the strongest possible, still safe, practical magnetic fields). We consider dynamic magnetic actuation and present initial results that show it is possible to vary magnets one against the other to focus carriers between them on average. The many remaining tasks for deep targeting in-vivo are then briefly noted.     

In vitro study of ferromagnetic stents for implant assisted-magnetic drug targeting

Implant-assisted-magnetic drug targeting (IA-MDT) was studied in vitro using a coiled ferromagnetic wire stent made from stainless steel 430 or 304, and magnetic drug carrier particle (MDCP) surrogates composed of poly(styrene/divinylbenzene) embedded with 20 wt% magnetite. The fluid velocity, particle concentration, magnetic field strength, and stent material all proved to be important for capturing the MDCP surrogates. Overall, this in vitro study further confirmed the important role of the ferromagnetic implant for attracting and retaining MDCPs at the target zone.